Abiopharma

🔍 Hom Donald S (Executive)

Company: NorthEast Community Bancorp, Inc./MD/ (NECB)

Report Date: 2026-07-29

Detailed Transactions and Holdings:

• Sold 3,000 shares of Common Stock at $27.1978 per share (Direct)
  Date: 2026-07-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,714.00 | transaction_form_type: 4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-29 | Code: H | nature_of_ownership: By ESOP | shares_owned_after: 14,703.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-29 | Code: H | nature_of_ownership: By IRA | shares_owned_after: 8,952.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-29 | Code: H | nature_of_ownership: By Stock Award | shares_owned_after: 13,307.00 | Footnotes: F1
• Holds 82,164 shares of Stock Option (right to buy) at $14.08 per share (Derivative)
  Date: 2026-07-29 | Code: H | Expires: 2032-11-17 | Exercise: 2023-11-17 | shares_owned_after: 82,164.00 | Footnotes: F2

Footnotes:

• F1: Stock Awards granted pursuant to the NorthEast Community Bancorp, Inc. 2022 Equity Incentive Plan vest in five approximately equal annual installments commencing on November 17, 2023.
• F2: Stock Options granted pursuant to the NorthEast Community Bancorp, Inc. 2022 Equity Incentive Plan vest in five approximately equal annual installments commencing on November 17, 2023.